Tuyen Bui

Recent publications by Tuyen Bui

1. Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injuryBMC Neuroscience · Wed,
2. IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancernpj Precision Oncology · Fri,
3. Data from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancersMon,
4. Supplementary Materials and Methods from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancersMon,
5. Supplemental Figures and Figure Legends from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancersMon,
6. Supplementary Materials and Methods from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancersMon,
7. Supplemental Figures and Figure Legends from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancersMon,
8. Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerCancer Research · Mon,
9. Abstract PO1-18-05: Combination treatment with CDK2 inhibitor (BLU-222) and either palbociclib or ribociclib is synergistic in pre-clinical models of CDK4/6 inhibitor-resistant breast cancerCancer Research · Thu,
10. Abstract PO3-15-03: Abemaciclib is effective in palbociclib resistant estrogen receptor positive breast cancersCancer Research · Thu,